Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 1
1979 1
1980 1
1981 1
1983 2
1984 1
1985 2
1986 5
1988 2
1989 4
1990 1
1991 7
1992 12
1993 5
1994 11
1995 14
1996 13
1997 9
1998 13
1999 12
2000 9
2001 7
2002 7
2003 4
2004 7
2005 4
2006 2
2007 9
2008 4
2009 8
2010 7
2011 7
2012 2
2013 6
2014 2
2015 6
2016 2
2017 2
2018 4
2019 1
2020 1
2021 2
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

212 results
Results by year
Filters applied: . Clear all
Page 1
The Use of Immunotherapy to Treat Metastatic Breast Cancer.
Nicolini A, Barak V, Biava P, Ferrari P, Rossi G, Carpi A. Nicolini A, et al. Among authors: barak v. Curr Med Chem. 2019;26(6):941-962. doi: 10.2174/0929867325666180209124052. Curr Med Chem. 2019. PMID: 29424297 Review.
Clinical utility of cytokeratins as tumor markers.
Barak V, Goike H, Panaretakis KW, Einarsson R. Barak V, et al. Clin Biochem. 2004 Jul;37(7):529-40. doi: 10.1016/j.clinbiochem.2004.05.009. Clin Biochem. 2004. PMID: 15234234 Review.
Optimal Use of Biomarkers in Oncology.
Karlikova M, Topolcan O, Wolfe OT, Barak V, Zima T. Karlikova M, et al. Among authors: barak v. Biomed Res Int. 2015;2015:423159. doi: 10.1155/2015/423159. Epub 2015 Aug 4. Biomed Res Int. 2015. PMID: 26345426 Free PMC article. No abstract available.
[Male breast cancer].
Roisman I, Gimon Z, Barak V. Roisman I, et al. Among authors: barak v. Harefuah. 1989 Aug;117(3-4):68-74. Harefuah. 1989. PMID: 2680825 Review. Hebrew. No abstract available.
212 results